Published in Cancer Weekly, December 28th, 2004
According to published research from Germany, "Prolonged pre-transplant IFN administration in patients with chronic myeloid leukemia has been associated with an increased risk of fatal transplant-related complications and an inferior outcome after allogeneic bone marrow transplantation."
"Using a two-stage long-term bone marrow culture as an in vitro model we were able to show a negative effect of higher doses of IFN pre-treatment of bone marrow stroma on hematopoiesis. This correlated with a decline in the number of monocytes-macrophages," reported C. Kasper and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.